<--- Back to Details
First PageDocument Content
Encephalitis / Viral encephalitis / Viral diseases / Neglected diseases / Tropical diseases / Murray Valley encephalitis virus / Japanese encephalitis / Mosquito / Kunjin virus / Health / Medicine / Microbiology
Date: 2015-03-24 00:45:23
Encephalitis
Viral encephalitis
Viral diseases
Neglected diseases
Tropical diseases
Murray Valley encephalitis virus
Japanese encephalitis
Mosquito
Kunjin virus
Health
Medicine
Microbiology

http://www.health.qld.gov.au Version: 5. 22nd February, 2011 Murray Valley Encephalitis Description: Encephalitis is an inflammation of the brain tissue and is usually caused by an infectious agent such as a virus.

Add to Reading List

Source URL: www.mcaa.org.au

Download Document from Source Website

File Size: 37,94 KB

Share Document on Facebook

Similar Documents

Soma markt wolkersdorf. Louis encephalitis principally affects wlkersdorf elderly, whereas Japanese encephalitis and eastern equine encephalitis have a wolkersdofr incidence, striking both soma markt wolkersdorf and elde

Soma markt wolkersdorf. Louis encephalitis principally affects wlkersdorf elderly, whereas Japanese encephalitis and eastern equine encephalitis have a wolkersdofr incidence, striking both soma markt wolkersdorf and elde

DocID: 1tcQH - View Document

JAPANESE ENCEPHALITIS Aetiology Epidemiology Diagnosis Prevention and Control References AETIOLOGY Classification of the causative agent Japanese encephalitis (JE) virus is a member of the family Flaviviridae, genus Flav

JAPANESE ENCEPHALITIS Aetiology Epidemiology Diagnosis Prevention and Control References AETIOLOGY Classification of the causative agent Japanese encephalitis (JE) virus is a member of the family Flaviviridae, genus Flav

DocID: 1slxi - View Document

Microsoft PowerPoint - W_Bossert_Molekulare Diagnostik 2013_WNV.ppt

Microsoft PowerPoint - W_Bossert_Molekulare Diagnostik 2013_WNV.ppt

DocID: 1r6Sk - View Document

FOR IMMEDIATE RELEASE Contact: Dr. Elliot Parks, HAWAII BIOTECH INITIATES PHASE 1 CLINICAL TRIAL FOR DENGUE VACCINE (HONOLULU, August 25, Hawaii Biotech, Inc. President and CEO Elliot Parks, Ph.D.,

FOR IMMEDIATE RELEASE Contact: Dr. Elliot Parks, HAWAII BIOTECH INITIATES PHASE 1 CLINICAL TRIAL FOR DENGUE VACCINE (HONOLULU, August 25, Hawaii Biotech, Inc. President and CEO Elliot Parks, Ph.D.,

DocID: 1qQgO - View Document

Microsoft Word - WEBSITE TBE GRANT RELEASE.doc

Microsoft Word - WEBSITE TBE GRANT RELEASE.doc

DocID: 1qLjw - View Document